For the 9^th year, locally owned Enmarket continued its partnership with the Georgia – South Carolina Region of The Leukemia & Lymphoma Society’s (LLS) Light The Night campaign. Enmarket launched its company-wide initiative across Georgia, South Carolina, and North Carolina by encouraging its customers to donate at check-out to benefit LLS. This year’s campaign raised over $125,000 to help in the fight against blood cancers. Brett Giesick, President of Enmarket, and Matt Clements, Vice President of Marketing, presented local LLS staff with a check last week.

“Over the past nine years, Enmarket’s customers have joined with us in raising nearly $900,000 to benefit The Leukemia & Lymphoma Society during this campaign,” said Giesick. “Next year, when we support Light The Night for the tenth year, our goal is to cross the million-dollar mark.”

Light The Night is a series of fundraising campaigns benefiting LLS and their funding of research to find blood cancer cures. Coming together for a common goal, friends, family and co-workers form fundraising walk teams and gather together to celebrate, honor or remember those touched by cancer. Millions of consumers also help by donating at retail outlets. Culminating in inspiration and memorable evening walks every fall, participants in 140 communities across North America join together carrying illuminated lanterns to take steps to end cancer – white for survivors, red for supporters and gold in memory of loved ones lost to cancer.

“We are so grateful to Enmarket and their employees who are relentless in their support of LLS and our mission to find better, safer cures for blood cancers,” said Amanda Yancey, LLS Georgia – South Carolina Executive Director. “At Light The Night, we aim to bring light to the darkness of cancer through research and cures. We are taking steps to end cancer and we won’t stop until we live in a world without blood cancer.”

The funds raised through Light The Night are used for:

Since its founding in 1949, LLS has invested more than $1.3 billion in cutting edge blood cancer research worldwide, and its support has been instrumental in the development of nearly every breakthrough in blood cancer treatment. To address the unique concerns of blood cancer patients throughout the COVID-19 pandemic, LLS has amplified its longstanding efforts to provide free information and support to blood cancer patients and their families, while also advocating for policies that will protect patients.